BlackRock Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

BlackRock Advisors’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$37K	Hold	7,068	–	–	﹤0.01%	3332
2016 Q3	$33K	Buy	7,068 +4,886	+224%	+$22.8K	﹤0.01%	3352
2016 Q2	$9K	Hold	2,182	–	–	﹤0.01%	3609
2016 Q1	$7K	Hold	2,182	–	–	﹤0.01%	3644
2015 Q4	$10K	Buy	+2,182	New	+$10.3K	﹤0.01%	3636
2015 Q2	–	Sell	-10,752	Closed	-$91K	–	3831
2015 Q1	$91K	Buy	10,752 +1,835	+21%	+$15.6K	﹤0.01%	3085
2014 Q4	$83K	Sell	8,917 -610	-6%	-$5.3K	﹤0.01%	3136
2014 Q3	$79K	Hold	9,527	–	–	﹤0.01%	3129
2014 Q2	$110K	Sell	9,527 -1,022	-10%	-$10.5K	﹤0.01%	3002
2014 Q1	$134K	Buy	10,549 +3,934	+59%	+$50.9K	﹤0.01%	2891
2013 Q4	$72K	Buy	6,615 +315	+5%	+$3.66K	﹤0.01%	3163
2013 Q3	$78K	Buy	6,300 +120	+2%	+$1.66K	﹤0.01%	3073
2013 Q2	$83K	Buy	+6,180	New	+$79.5K	﹤0.01%	3000

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Advisors's DSCI Position: Q4 2016 in Review

BlackRock Advisors held its Derma Sciences, Inc. Common Stock (DE) (DSCI) position steady in Q4 2016 at 7,068 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

BlackRock Advisors first reported a position in DSCI in Q2 2013 and has held it in 13 quarters since. The position peaked at $134K in Q1 2014. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

BlackRock Advisors held 7,068 shares of Derma Sciences, Inc. Common Stock (DE) worth $37K as of Q4 2016.
BlackRock Advisors left its Derma Sciences, Inc. Common Stock (DE) share count unchanged in Q4 2016.
Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3332 holding.
BlackRock Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 13 quarters since.
BlackRock Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $134K in Q1 2014.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.